Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: A randomized, 28-day, dose-ranging trial

Maribel Rodriguez-Torres, Eric Lawitz, Kris V. Kowdley, David R. Nelson, Edwin Dejesus, John G. McHutchison, Melanie T. Cornpropst, Michael Mader, Efsevia Albanis, Deyuan Jiang, Christy M. Hebner, William T. Symonds, Michelle M. Berrey, Jay Lalezari

Research output: Contribution to journal › Article › peer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: A randomized, 28-day, dose-ranging trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science